The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
Targeting EMT in cancer: opportunities for pharmacological intervention
Open accessAbstract
The spread of cancer cells to distant organs represents a major clinical challenge in the treatment of cancer. Epithelial-mesenchymal transition (EMT) has emerged as a key regulator of metastasis in some cancers by conferring an invasive phenotype. As well as facilitating metastasis, EMT is thought to generate cancer stem cells and contribute to therapy resistance. Therefore, the EMT pathway is of great therapeutic interest in the treatment of cancer and could be targeted either to prevent tumor dissemination in patients at high risk of developing metastatic lesions or to eradicate existing metastatic cancer cells in patients with more advanced disease. In this review, we discuss approaches for the design of EMT-based therapies in cancer, summarize evidence for some of the proposed EMT targets, and review the potential advantages and pitfalls of each approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Lahat, G., Zhu, Q.-S., Huang, K.-L., Wang, S., Bolshakov, S., Liu, J., Torres, K., Langley, R. R., Lazar, A. J., Hung, M. C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010105 · Cited by 213
RetractedDinh (2010) · International Journal of Oncology · doi:10.3892/ijo.2010.883 · Cited by 59
RetractedLee, S.-L., Chou, C.-C., Chuang, H.-C., Hsu, E., Chiu, P.-C., Kulp, S. K., Byrd, J. C., & Chen, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067149 · Cited by 33
RetractedZhu, J., Pan, X., Zhang, Z., Gao, J., Zhang, L., & Chen, J. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.02.013 · Cited by 31
RetractedThe basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
A Perspective on Cancer Cell Metastasis
Chaffer, C. L., & Weinberg, R. A. (2011) · Science · doi:10.1126/science.1203543 · Cited by 4,807
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Yu, M., Bardia, A., Wittner, B. S., Stott, S. L., Smas, M. E., Ting, D. T., Isakoff, S. J., Ciciliano, J. C., Wells, M. N., Shah, A. M., et al. (2013) · Science · doi:10.1126/science.1228522 · Cited by 2,476
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,389
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Prat, A., Parker, J. S., Karginova, O., Fan, C., Livasy, C., Herschkowitz, J. I., He, X., & Perou, C. M. (2010) · Breast Cancer Research · doi:10.1186/bcr2635 · Cited by 2,167
An Overview of Epithelio-Mesenchymal Transformation
Hay, E. D. (1995) · Cells Tissues Organs · doi:10.1159/000147748 · Cited by 1,567
MicroRNAs and other non-coding RNAs as targets for anticancer drug development
Ling, H., Fabbri, M., & Calin, G. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4140 · Cited by 1,465
Creighton, C. J., Li, X., Landis, M., Dixon, J. M., Neumeister, V. M., Sjolund, A., Rimm, D. L., Wong, H., Rodriguez, A., Herschkowitz, J. I., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905718106 · Cited by 1,412
Stattic: a small-molecule inhibitor of STAT3 activation and dimerization
Schust, J., Sperl, B., Hollis, A., Mayer, T. U., & Berg, T. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.09.018 · Cited by 1,105
Tsai, J. H., Donaher, J. L., Murphy, D. A., Chau, S., & Yang, J. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.022 · Cited by 1,071
Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype
Sarrió, D., Rodriguez-Pinilla, S. M., Hardisson, D., Cano, A., Moreno-Bueno, G., & Palacios, J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2017 · Cited by 1,056
Liu, S., Cong, Y., Wang, D., Sun, Y., Deng, L., Liu, Y., Martin-Trevino, R., Shang, L., McDermott, S. P., Landis, M. D., et al. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.11.009 · Cited by 1,053
Ocaña, O. H., Córcoles, R., Fabra, Á., Moreno-Bueno, G., Acloque, H., Vega, S., Barrallo-Gimeno, A., Cano, A., & Nieto, M. A. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.10.012 · Cited by 973
Snail blocks the cell cycle and confers resistance to cell death
Vega, S., Morales, A. V., Ocaña, O. H., Valdés, F., Fabregat, I., & Nieto, M. A. (2004) · Genes & Development · doi:10.1101/gad.294104 · Cited by 867
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
Arumugam, T., Ramachandran, V., Fournier, K. F., Wang, H., Marquis, L., Abbruzzese, J. L., Gallick, G. E., Logsdon, C. D., McConkey, D. J., & Choi, W. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2819 · Cited by 863
Trends in the exploitation of novel drug targets
Rask-Andersen, M., Almén, M. S., & Schiöth, H. B. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3478 · Cited by 853
Siddiquee, K., Zhang, S., Guida, W. C., Blaskovich, M. A., Greedy, B., Lawrence, H. R., Yip, M. L. R., Jove, R., McLaughlin, M. M., Lawrence, N. J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609757104 · Cited by 736
The Ins and Outs of the Epithelial to Mesenchymal Transition in Health and Disease
Nieto, M. A. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154036 · Cited by 720
Thomson, S., Buck, E., Petti, F., Griffin, G., Brown, E., Ramnarine, N., Iwata, K. K., Gibson, N., & Haley, J. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1058 · Cited by 663
Vuoriluoto, K., Haugen, H., Kiviluoto, S., Mpindi, J.-P., Nevo, J., Gjerdrum, C., Tiron, C., Lorens, J. B., & Ivaska, J. (2011) · Oncogene · doi:10.1038/onc.2010.509 · Cited by 647
Lo, H.-W., Hsu, S.-C., Xia, W., Cao, X., Shih, J.-Y., Wei, Y., Abbruzzese, J. L., Hortobagyi, G. N., & Hung, M.-C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0575 · Cited by 625
Wang, Z., Li, Y., Kong, D., Banerjee, S., Ahmad, A., Azmi, A. S., Ali, S., Abbruzzese, J. L., Gallick, G. E., & Sarkar, F. H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4312 · Cited by 619
Gjerdrum, C., Tiron, C., Høiby, T., Stefansson, I., Haugen, H., Sandal, T., Collett, K., Li, S., McCormack, E., Gjertsen, B. T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909333107 · Cited by 594
Holland, S. J., Pan, A., Franci, C., Hu, Y., Chang, B., Li, W., Duan, M., Torneros, A., Yu, J., Heckrodt, T. J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2997 · Cited by 550
The Fallacy of Epithelial Mesenchymal Transition in Neoplasia
Tarin, D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0699 · Cited by 531
Yadav, A., Kumar, B., Datta, J., Teknos, T. N., & Kumar, P. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0271 · Cited by 503
Chaffer, C. L., Brennan, J. P., Slavin, J. L., Blick, T., Thompson, E. W., & Williams, E. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2044 · Cited by 455
Self-citationCelià-Terrassa, T., Meca-Cortés, Ó., Mateo, F., Martínez de Paz, A., Rubio, N., Arnal-Estapé, A., Ell, B. J., Bermudo, R., Díaz, A., Guerra-Rebollo, M., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59218 · Cited by 450
Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis
Jung, Y., Kim, J. K., Shiozawa, Y., Wang, J., Mishra, A., Joseph, J., Berry, J. E., McGee, S., Lee, E., Sun, H., et al. (2013) · Nature Communications · doi:10.1038/ncomms2766 · Cited by 423
Dasgupta, P., Rizwani, W., Pillai, S., Kinkade, R., Kovacs, M., Rastogi, S., Banerjee, S., Carless, M., Kim, E., Coppola, D., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.23894 · Cited by 383
Direct Evidence for Epithelial-Mesenchymal Transitions in Breast Cancer
Trimboli, A. J., Fukino, K., de Bruin, A., Wei, G., Shen, L., Tanner, S. M., Creasap, N., Rosol, T. J., Robinson, M. L., Eng, C., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2148 · Cited by 368
Yoo, Y. A., Kang, M. H., Lee, H. J., Kim, B.-H., Park, J. K., Kim, H. K., Kim, J. S., & Oh, S. C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1338 · Cited by 340
Mesenchymal–epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer
Gunasinghe, N. P. A. D., Wells, A., Thompson, E. W., & Hugo, H. J. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9377-5 · Cited by 339
Self-citationTanaka, H., Kono, E., Tran, C. P., Miyazaki, H., Yamashiro, J., Shimomura, T., Fazli, L., Wada, R., Huang, J., Vessella, R. L., et al. (2010) · Nature Medicine · doi:10.1038/nm.2236 · Cited by 339
Davis, F. M., Azimi, I., Faville, R. A., Peters, A. A., Jalink, K., Putney, J. W., Goodhill, G. J., Thompson, E. W., Roberts-Thomson, S. J., & Monteith, G. R. (2014) · Oncogene · doi:10.1038/onc.2013.187 · Cited by 333
Self-citationColomiere, M., Ward, A. C., Riley, C., Trenerry, M. K., Cameron-Smith, D., Findlay, J., Ackland, L., & Ahmed, N. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604794 · Cited by 320
Epithelial to mesenchymal transition and breast cancer
Tomaskovic-Crook, E., Thompson, E. W., & Thiery, J. P. (2009) · Breast Cancer Research · doi:10.1186/bcr2416 · Cited by 318
Self-citationMarino, N., Woditschka, S., Reed, L. T., Nakayama, J., Mayer, M., Wetzel, M., & Steeg, P. S. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.06.012 · Cited by 309
Xiong, H., Hong, J., Du, W., Lin, Y.-W., Ren, L.-L., Wang, Y.-C., Su, W.-Y., Wang, J.-L., Cui, Y., Wang, Z.-H., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.295964 · Cited by 307
Asiedu, M. K., Beauchamp-Perez, F. D., Ingle, J. N., Behrens, M. D., Radisky, D. C., & Knutson, K. L. (2014) · Oncogene · doi:10.1038/onc.2013.57 · Cited by 303
Thaiparambil, J. T., Bender, L., Ganesh, T., Kline, E., Patel, P., Liu, Y., Tighiouart, M., Vertino, P. M., Harvey, R. D., Garcia, A., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25938 · Cited by 289
Halder, S. K., Beauchamp, R. D., & Datta, P. K. (2005) · Neoplasia · doi:10.1593/neo.04640 · Cited by 288
Sparano, J. A., Bernardo, P., Stephenson, P., Gradishar, W. J., Ingle, J. N., Zucker, S., & Davidson, N. E. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.054 · Cited by 269
Zuo, J., Zhu, W., Li, M., Li, X., Yi, H., Zeng, G., Wan, X., He, Q., Li, J., Qu, J., et al. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23175 · Cited by 258
Lee, M.-Y., Chou, C.-Y., Tang, M.-J., & Shen, M.-R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0234 · Cited by 256
uPAR induces epithelial–mesenchymal transition in hypoxic breast cancer cells
Lester, R. D., Jo, M., Montel, V., Takimoto, S., & Gonias, S. L. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200701092 · Cited by 253
Epithelial-to-Mesenchymal Transitions and Circulating Tumor Cells
Bonnomet, A., Brysse, A., Tachsidis, A., Waltham, M., Thompson, E. W., Polette, M., & Gilles, C. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9174-0 · Cited by 227
Self-citationJung, A., Schrauder, M., Oswald, U., Knoll, C., Sellberg, P., Palmqvist, R., Niedobitek, G., Brabletz, T., & Kirchner, T. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63007-6 · Cited by 217
Plasticity of disseminating cancer cells in patients with epithelial malignancies
Bednarz-Knoll, N., Alix-Panabières, C., & Pantel, K. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9370-z · Cited by 214
Koorstra, J.-B. M., Karikari, C., Feldmann, G., Bisht, S., Leal-Rojas, P., Offerhaus, G. J. A., Alvarez, H., & Maitra, A. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.7.7923 · Cited by 205
Bonnomet, A., Syne, L., Brysse, A., Feyereisen, E., Thompson, E. W., Noël, A., Foidart, J.-M., Birembaut, P., Polette, M., & Gilles, C. (2012) · Oncogene · doi:10.1038/onc.2011.540 · Cited by 201
Self-citationXie, M., Zhang, L., He, C., Xu, F., Liu, J., Hu, Z., Zhao, L., & Tian, Y. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24019 · Cited by 191
Thomson, S., Petti, F., Sujka-Kwok, I., Epstein, D., & Haley, J. D. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9200-4 · Cited by 190
Shi, Z., Zhang, J., Qian, X., Han, L., Zhang, K., Chen, L., Liu, J., Ren, Y., Yang, M., Zhang, A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0280 · Cited by 190
Kang, J., Kim, E., Kim, W., Seong, K. M., Youn, H., Kim, J. W., Kim, J., & Youn, B. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.490482 · Cited by 188
Rosanò, L., Cianfrocca, R., Spinella, F., Di Castro, V., Nicotra, M. R., Lucidi, A., Ferrandina, G., Natali, P. G., & Bagnato, A. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2325 · Cited by 187
Lin, C., Tsai, P., Kandaswami, C. C., Lee, P., Huang, C., Hwang, J., & Lee, M. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01861.x · Cited by 185
Li, X., Ma, Q., Xu, Q., Liu, H., Lei, J., Duan, W., Bhat, K., Wang, F., Wu, E., & Wang, Z. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.02.035 · Cited by 181
Endothelin-1 Promotes Epithelial-to-Mesenchymal Transition in Human Ovarian Cancer Cells
Rosanò, L., Spinella, F., Di Castro, V., Nicotra, M. R., Dedhar, S., de Herreros, A. G., Natali, P. G., & Bagnato, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2123 · Cited by 173
Suman, S., Das, T. P., & Damodaran, C. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.642 · Cited by 166
Shintani, Y., Okimura, A., Sato, K., Nakagiri, T., Kadota, Y., Inoue, M., Sawabata, N., Minami, M., Ikeda, N., Kawahara, K., et al. (2011) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2011.07.032 · Cited by 159
Marangoni, E., Lecomte, N., Durand, L., Pinieux, G. D. B. D., Decaudin, D., Chomienne, C., Smadja‐Joffe, F., & Poupon, M. F. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604953 · Cited by 157
Güngör, C., Zander, H., Effenberger, K. E., Vashist, Y. K., Kalinina, T., Izbicki, J. R., Yekebas, E. F., & Bockhorn, M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0036 · Cited by 157
Lei, J., Ma, J., Ma, Q., Li, X., Liu, H., Xu, Q., Duan, W., Sun, Q., Xu, J., Wu, Z., et al. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-66 · Cited by 155
Sarrió, D., Franklin, C. K., Mackay, A. G., Reis-Filho, J. S., & Isacke, C. M. (2011) · Stem Cells · doi:10.1002/stem.791 · Cited by 153
Yu, F., Jiao, Y., Zhu, Y., Wang, Y., Zhu, J., Cui, X., Liu, Y., He, Y., Park, E.-Y., Zhang, H., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.280768 · Cited by 152
Zhau, H. E., Odero-Marah, V., Lue, H.-W., Nomura, T., Wang, R., Chu, G. C., Liu, Z., Zhou, B. P., Huang, W., & Chung, L. W. K. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9183-1 · Cited by 149
Hance, M. W., Dole, K., Gopal, U., Bohonowych, J. E. S., Jezierska‐Drutel, A., Neumann, C. A., Liu, H., Garraway, I. P., & Isaacs, J. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.389015 · Cited by 147
Serrano, I., McDonald, P. C., Lock, F. E., & Dedhar, S. (2012) · Oncogene · doi:10.1038/onc.2012.30 · Cited by 146
Balanis, N. G., Wendt, M. K., Schiemann, B. J., Wang, Z., Schiemann, W. P., & Carlin, C. R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.475277 · Cited by 141
Yue, P., Zhang, X., Paladino, D., Sengupta, B., Ahmad, S., Holloway, R. W., Ingersoll, S. B., & Turkson, J. (2011) · Oncogene · doi:10.1038/onc.2011.409 · Cited by 140
Shao, M., Cao, L., Shen, C., Satpathy, M., Chelladurai, B. S., Bigsby, R. M., Nakshatri, H., & Matei, D. E. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1257 · Cited by 139
Yoon, Y., Liang, Z., Zhang, X., Choe, M., Zhu, A., Cho, H. T., Shin, D. M., Goodman, M. M., Chen, Z., & Shim, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2263 · Cited by 134
Zhang, D., LaFortune, T. A., Krishnamurthy, S., Esteva, F. J., Cristofanilli, M., Liu, P., Lucci, A., Singh, B., Hung, M., Hortobágyi, G. N., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0951 · Cited by 134
Ogunwobi, O. O., & Liu, C. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9404-x · Cited by 131
Lee, H., Jeng, Y., Chen, Y., Chung, L., & Yuan, R. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt372 · Cited by 131
Breast cancer stem cells and epithelial mesenchymal plasticity – Implications for chemoresistance
Pinto, C., Widodo, E., Waltham, M. C., & Thompson, E. W. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.06.003 · Cited by 130
Self-citationBertrán, E., Crosas‐Molist, E., Sancho, P., Caja, L., López‐Luque, J., Navarro, E., Egea, G., Lastra, R., Serrano, T., Ramos, E., et al. (2013) · Hepatology · doi:10.1002/hep.26597 · Cited by 129
Zhang, W., Feng, M., Zheng, G., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.11.142 · Cited by 122
Bocca, C., Ievolella, M., Autelli, R., Motta, M., Mosso, L., Torchio, B., Bozzo, F., Cannito, S., Paternostro, C., Colombatto, S., et al. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.860447 · Cited by 120
Dovizio, M., Maier, T. J., Alberti, S., Francesco, L. D., Marcantoni, E., Münch, G., John, C. M., Suess, B., Sgambato, A., Steinhilber, D., et al. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.084988 · Cited by 120
Dunne, P. D., McArt, D. G., Blayney, J. K., Kalimutho, M., Greer, S., Wang, T., Srivastava, S., Ong, C. W., Arthur, K., Loughrey, M. B., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1354 · Cited by 119
Hypoxia Stabilizes GAS6/Axl Signaling in Metastatic Prostate Cancer
Mishra, A., Wang, J., Shiozawa, Y., McGee, S., Kim, J., Jung, Y., Joseph, J., Berry, J. E., Havens, A. M., Pienta, K. J., et al. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0569 · Cited by 116
Li, H. Y., Wang, H., Wang, F., Gu, Q., & Xu, X. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023322 · Cited by 114
Lue, H.-W., Yang, X., Wang, R., Qian, W., Xu, R. Z. H., Lyles, R. H., Osunkoya, A. O., Zhou, B. P., Vessella, R. L., Zayzafoon, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027720 · Cited by 113
Comamala, M., Pinard, M., Thériault, C., Matte, I., Albert, A., Boivin, M., Beaudin, J., Piché, A., & Rancourt, C. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.34 · Cited by 111
Nanta, R., Kumar, D., Meeker, D. G., Rodova, M., Veldhuizen, P. J. V., Shankar, S., & Srivastava, R. K. (2013) · Oncogenesis · doi:10.1038/oncsis.2013.5 · Cited by 110
Chang, W., Lin, R., Yu, J., Chang, W., Fu, C.-H., Lai, A. C., Yu, A. L.-T., & Yu, A. L.-T. (2013) · Breast Cancer Research · doi:10.1186/bcr3423 · Cited by 108
Xie, M., He, C.-S., Wei, S., & Zhang, L. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.07.007 · Cited by 107
Toiyama, Y., Yasuda, H., Saigusa, S., Matushita, K., Fujikawa, H., Tanaka, K., Mohri, Y., Inoue, Y., Goel, A., & Kusunoki, M. (2011) · International Journal of Cancer · doi:10.1002/ijc.26330 · Cited by 100
The to and fro of tumour spread
van Denderen, B. J. W., & Thompson, E. W. (2013) · Nature · doi:10.1038/493487a · Cited by 99
Self-citationInhibition of SHP2 leads to mesenchymal to epithelial transition in breast cancer cells
Zhou, X.-D., & Agazie, Y. M. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.54 · Cited by 97
Keysar, S. B., Le, P. N., Anderson, R. T., Morton, J. J., Bowles, D. W., Paylor, J. J., Vogler, B. W., Thorburn, J., Fernandez, P., Glogowska, M. J., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4047 · Cited by 97
Notch1‐Snail1‐E‐cadherin pathway in metastatic hepatocellular carcinoma
Wang, X. Q., Zhang, W., Lui, E. L. H., Zhu, Y., Lü, P., Yu, X., Sun, J.-S., Yang, S., Poon, R. T. P., & Fan, S. T. (2011) · International Journal of Cancer · doi:10.1002/ijc.27336 · Cited by 95
Vázquez‐Martín, A., Cufí, S., Oliveras‐Ferraros, C., Torres-Garcia, V. Z., Corominas-Faja, B., Cuyàs, E., Bonavia, R., Visa, J., Martín-Castillo, B., Barrajón‐Catalán, E., et al. (2013) · Scientific Reports · doi:10.1038/srep02560 · Cited by 94
Nicotine Enhances Colon Cancer Cell Migration by Induction of Fibronectin
Wei, P., Kuo, L., Huang, M., Ting, W.-C., Ho, Y., Wang, W., An, J., & Chang, Y. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1504-3 · Cited by 90
Matsuno, Y., Coelho, A. L., Járai, G., Westwick, J. K., & Hogaboam, C. M. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.01.021 · Cited by 86
Wei, P., Chang, Y., Ho, Y., Lee, C., Yang, Y.-Y., An, J., & Lin, S.-Y. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181a6ce7e · Cited by 78
Bertrán, E., Caja, L., Navarro, E., Sancho, P., Mainez, J., Murillo, M. M., Vinyals, A., Fabra, À., & Fabregat, I. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.06.006 · Cited by 75
Hugo, H. J., Pereira, L. A., Suryadinata, R., Drabsch, Y., Gonda, T. J., Gunasinghe, N. P. A. D., Pinto, C., Soo, E., van Denderen, B. J. W., Hill, P., et al. (2013) · Breast Cancer Research · doi:10.1186/bcr3580 · Cited by 75
Self-citationIntegrin‐linked kinase regulates E‐cadherin expression through PARP‐1
McPhee, T. R., McDonald, P. C., Oloumi, A., & Dedhar, S. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21685 · Cited by 74
Role of vimentin in smooth muscle force development
Wang, R., Li, Q., & Tang, D. D. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00097.2006 · Cited by 68
Zip6-attenuation promotes epithelial-to-mesenchymal transition in ductal breast tumor (T47D) cells
López, V., & Kelleher, S. L. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.10.011 · Cited by 67
LIV-1 suppression inhibits HeLa cell invasion by targeting ERK1/2-Snail/Slug pathway
Zhao, L., Chen, W., Taylor, K. M., Cai, B., & Li, X. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.127 · Cited by 67
Cheng, J.-C., Auersperg, N., & Leung, P. C. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034071 · Cited by 66
KCNN4 Channels participate in the EMT induced by PRL-3 in colorectal cancer
Wei, L., Liu, L., Zeng, Y., Wu, H., Xu, H., Chen, S., & Chu, Z. (2013) · Medical Oncology · doi:10.1007/s12032-013-0566-z · Cited by 65
Lin, C., Tsai, P.-H., Kandaswami, C. C., Chang, G.-D., Cheng, C., Huang, C., Lee, P.-P., Hwang, J.-J., & Lee, M. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-87 · Cited by 62
TACC3 Is Essential for EGF-Mediated EMT in Cervical Cancer
Ha, G., Kim, J., & Breuer, E.-K. Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070353 · Cited by 62
Axl Is a Prognostic Marker in Oral Squamous Cell Carcinoma
Lee, C., Yen, C.-Y., Liu, S.-Y., Chen, C.-K., Chiang, C., Shiah, S., Chen, P.-H., & Shieh, Y. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1985-8 · Cited by 62
Satoh (2009) · International Journal of Oncology · doi:10.3892/ijo_00000394 · Cited by 62
Zhao, H., Desai, V., Wang, J., Epstein, D. M., Miglarese, M. R., & Buck, E. A. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0327 · Cited by 62
Ogunwobi, O. O., Wang, T., Zhang, L., & Liu, C. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06980.x · Cited by 61
Adhim, Z., Matsuoka, T., Bito, T., Shigemura, K., Lee, K.-M., Kawabata, M., Fujisawa, M., Nibu, K., & Shirakawa, T. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.262 · Cited by 59
Loss of EBP50 stimulates EGFR activity to induce EMT phenotypic features in biliary cancer cells
Clapéron, A., Guedj, N., Mergey, M., Vignjevic, D. M., Desbois‐Mouthon, C., Boissan, M., Saubaméa, B., Paradis, V., Housset, C., & Fouassier, L. (2011) · Oncogene · doi:10.1038/onc.2011.334 · Cited by 59
Kirane, A., Toombs, J. E., Ostapoff, K. T., Carbon, J. G., Zaknoen, S. L., Braunfeld, J. B., Schwarz, R. E., Burrows, F. J., & Brekken, R. A. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0453 · Cited by 59
Davis, F. M., Kenny, P. A., Soo, E., van Denderen, B. J. W., Thompson, E. W., Cabot, P. J., Parat, M., Roberts‐Thomson, S. J., & Monteith, G. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023464 · Cited by 58
Self-citationLien, Y.-C., Wang, W., Kuo, L., Liu, J., Wei, P., Ho, Y., Ting, W.-C., Wu, C., & Chang, Y. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1598-2 · Cited by 58
Amatangelo, M. D., Goodyear, S. M., Varma, D. M., & Stearns, M. E. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs227 · Cited by 58
The importance of integrin‐linked kinase in the regulation of bladder cancer invasion
Matsui, Y., Assi, K., Ogawa, O., Raven, P. A., Dedhar, S., Gleave, M. E., Salh, B. S., & So, A. (2011) · International Journal of Cancer · doi:10.1002/ijc.26008 · Cited by 54
Role of fucosyltransferase IV in epithelial–mesenchymal transition in breast cancer cells
Yang, X., Liu, S., & Yan, Q. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.241 · Cited by 53
Monica, S. L., Caffarra, C., Saccani, F., Galvani, E., Galetti, M., Fumarola, C., Bonelli, M. A., Cavazzoni, A., Cretella, D., Sirangelo, R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078656 · Cited by 52
Mesenchymal to epithelial transition in sarcomas
Yang, J., Du, X., Wang, G., Sun, Y. K., Chen, K., Zhu, X., Lazar, A. J., Hunt, K. K., Pollock, R. E., & Zhang, W. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.11.006 · Cited by 52
MBP-1 Suppresses Growth and Metastasis of Gastric Cancer Cells through COX-2
Hsu, K., Hsieh, R., Wu, C.-W., Chi, C., Lee, Y. W., Kuo, M., Wu, K.-J., & Yeh, T.-S. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-05-0386 · Cited by 45
Targeting Met and Notch in theLfng-deficient,Met-amplified triple-negative breast cancer
Zhang, S., Chung, W.-C., Miele, L., & Xu, K. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.28180 · Cited by 43
Concordant correlation of LIV-1 and E-cadherin expression in human breast cancer cell MCF-7
Shen, H., Qin, H., & Guo, J. (2008) · Molecular Biology Reports · doi:10.1007/s11033-008-9225-4 · Cited by 35
Chang, Z., Wei, J., Qin, C.-F., Hao, K., Tian, X., Xie, K., Xie, X., & Yang, Y.-M. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2036-4 · Cited by 34
Negative Correlation of LIV-1 and E-Cadherin Expression in Hepatocellular Carcinoma Cells
Shen, R., Xie, F., Shen, H., liu, Q., Zheng, T., Kou, X., Wang, D., & Yang, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056542 · Cited by 29
Epithelial–mesenchymal transition increases tumor sensitivity to COX-2 inhibition by apricoxib
Kirane, A., Toombs, J. E., Larsen, J. E., Ostapoff, K. T., Meshaw, K. R., Zaknoen, S. L., Brekken, R. A., & Burrows, F. J. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs195 · Cited by 28
Peng, J., Zhang, G., Wang, Q., Huang, J., Ma, H., Zhong, Y., Zhou, F., Xie, C., & Zhang, A. (2012) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.110411 · Cited by 26
Sasaki, T., Kuniyasu, H., Luo, Y., Kato, D., Shinya, S., Fujii, K., Ohmori, H., & Yamashita, Y. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02264.x · Cited by 20
Gene silencing of c-Met leads to brain metastasis inhibitory effects
Lee, S. J., Seol, H. J., Lee, H. W., Kang, W. Y., Kang, B. G., Jin, J., Jo, M.-Y., Jin, Y., Lee, J.-I., Joo, K. M., et al. (2013) · Clinical & Experimental Metastasis · doi:10.1007/s10585-013-9584-7 · Cited by 12
Yan, Y., Ai, Z., Wang, J., Xu, Y., & Teng, Y. (2012) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e31826ed2be · Cited by 10
Downregulation of Axl in non-MYCN amplified neuroblastoma cell lines reduces migration
Duijkers, F. A. M., Meijerink, J. P. P., Pieters, R., & van Noesel, M. M. (2013) · Gene · doi:10.1016/j.gene.2013.03.029 · Cited by 10
Cited by
Epithelial Mesenchymal Transition in Tumor Metastasis
Mittal, V. (2018) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043854 · Cited by 1,528
Controversies around epithelial–mesenchymal plasticity in cancer metastasis
Williams, E. D., Gao, D., Redfern, A., & Thompson, E. W. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0213-x · Cited by 451
Self-citationNew insights into the role of EMT in tumor immune escape
Terry, S., Savagner, P., Ortiz‐Cuaran, S., Mahjoubi, L., Saintigny, P., Thiery, J., & Chouaib, S. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12093 · Cited by 414
Wu, Y., Yang, X., Chen, Z., Tian, L., Jiang, G., Chen, F., Li, J., An, P., Lu, L., Luo, N., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1014-2 · Cited by 392
Tumor Immune Microenvironment during Epithelial–Mesenchymal Transition
Taki, M., Abiko, K., Ukita, M., Murakami, R., Yamanoi, K., Yamaguchi, K., Hamanishi, J., Baba, T., Matsumura, N., & Mandai, M. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4459 · Cited by 351
Metadata
- Authors
- Davis, F. M., Stewart, T. A., Thompson, E. W., & Monteith, G. R.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2014-09
- Volume
- 35
- Issue
- 9
- Pages
- 479-488
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W2084863590
- Cited by
- 361
- References
- 141
- FWCI
- 2.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.